Evidence map›Paper›PMID 33794821›Full record

ArticleBMC cancer2021

Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study.

Anna Tisler, Sven Erik Ojavee, Piret Veerus, Pilleriin Soodla, Anneli Uusküla

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Bacterial Vaginosis Decreases the Risk of Cervical Cytological Abnormalities.Cancer prevention research (Philadelphia, Pa.) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Anna TislerInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia. annatisler@gmail.ee.ORCID http://orcid.org/0000-0002-2055-9421
Sven Erik OjaveeDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Piret VeerusNational Institute for Health Development, Tallinn, Estonia.
Pilleriin SoodlaDepartment of Internal Medicine, Tartu University Hospital, Tartu, Estonia.
Anneli UuskülaInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
University of Tartu · EENational Institute for Health Development · EETartu University Hospital · EEUniversity of Lausanne · CH

Funding

EEA EMP416
6 · The paper itself

Abstract

backgroundThe World Health Organisation (WHO) calls for the elimination of cervical cancer (CC) as a public health issue. To achieve elimination, efforts must be aligned and accelerated. Women living with HIV (WLWH) have excess risk for developing, and dying from, CC over the general population. Estimates of cervical cancer screening programme coverage in Eastern European countries that have experienced HIV epidemics since the early 2000's are scarce.

methodThis population-based retrospective study uses a healthcare administrative database and follows cohorts of all WLWH in a ratio of 1:3 randomly matched (age, region) HIV negative women from 2009 to 2018. Annual and longitudinal (over the whole study period) coverage for cervical cancer screening (opportunistic, organised, HIV specific) and adjusted odds ratios (AORs) for longitudinal screening coverage predictors were estimated from 2009 to 2018.

resultsAmong WLWH and HIV-negative women, the mean annual coverage with opportunistic screening was 61.45 and 65.59%; and organised screening was 20.4 and 28.7%, respectively (both: p < 0.00001). 19.01% (95% CI 18.05-19.97) HIV-negative and 13.9% (95% CI 12.35-15.45) WLWH were longitudinally covered with organised cervical cancer screening. Among WLWH, the mean annual HIV-specific cervical cancer screening coverage was 49.4, and 24.3% were longitudinally covered. Longitudinal coverage with HIV-specific cervical cancer screening was inversely associated with age, hepatitis C virus (HCV) co-infection (AOR 0.754, 95% CI 0.619, 0.916), not having insurance (AOR 0.331, 95% CI 0.264, 0.412), drug abuse (AOR 0.459, 95% CI 0.336, 0.618) and higher among those retained in HIV care (AOR 1.972, 95% CI 1.615, 2.410). Among HIV-negative women, longitudinal coverage with organised cervical cancer screening was inversely associated with residence in the region and higher among older women.

conclusionsOur results highlight unacceptably low coverage of cervical cancer screening of WLWH in Estonia. There is need for dedicated cervical cancer screening efforts for WLWH considering the high cancer risk and rate in the study population.

Indexed as

AdolescentAdultCohort StudiesEarly Detection of CancerEstoniaFemaleHIV InfectionsHumansLongitudinal StudiesMiddle AgedRetrospective StudiesUterine Cervical NeoplasmsYoung AdultCervical cancerHIVHuman papillomavirusPapanicolaou testScreening

Identifiers

PMID33794821
PMCPMC8017631
OpenAlexW3145314901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.